Covis Pharma's statement on to The Times about Makena
The FDA recommended that Covis Pharma's premature birth drug, Makena, be taken off the market. The company has refused. Covis has continued to promote Makena, emphasizing a need by Black women, who are most at risk of preterm births.
Kent Nishimura Los Angeles Gudemanjj Perinatol Covis Pharma Public Health Institute In Oakland American College Of Obstetricians Advisory Committee
Source: latimes.com